The results presented here support the idea that development of several triple negative breast cancers may involve expansion of cell populations with altered Smad2 and Smad3 levels resulting in Smad3 dependent expression of TMEPAI, which provides a competitive advantage for cancer cells to grow and metastasize in presence of TGF-β. Here, SMAD2 is linked to cancer.